Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$23.42 - $31.74 $234,200 - $317,400
-10,000 Reduced 21.48%
36,550 $1.13 Million
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $924,483 - $1.25 Million
46,550 New
46,550 $1.18 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $91,692 - $125,009
5,400 New
5,400 $107,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $11B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Saltoro Capital, LP Portfolio

Follow Saltoro Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saltoro Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Saltoro Capital, LP with notifications on news.